Indoleamine 2,3-dioxygenase-1 (IDO1) activity protects M. tuberculosis in macrophages from antibiotics Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019
In vitro and in vivo activity of thiourea (ISO), a mycolic acid inhibitor, against multi drug resistant (MDR) strains of Mycobacterium tuberculosis (M. tb )Source: Eur Respir J 2005; 26: Suppl. 49, 700s Year: 2005
Endogenous indoleamine 2,3-dioxygenase activity reduces local inflammatory cell numbers Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Increased Indoleamine 2,3-dioxygenase (IDO) activity as predictors of severity and outcome in patients with pneumonia Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
In vitro activity of triclosan ( TCN ) and thiolactomycin ( TLM ) against multi-drug-resistant ( MDR ) strains of mycobacterium tuberculosis ( M. tb ) Source: Eur Respir J 2004; 24: Suppl. 48, 722s Year: 2004
Transcriptional expression of human telomerase reverse transcriptase (hTERT) and indoleamine 2,3-dioxygenase (IDO) in non-small cell lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001
Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS) Source: Eur Respir J 2001; 18: Suppl. 33, 308s Year: 2001
In-vitro effect of bioactive fractions of Cinnamomum verum(Cv) on cytokine levels in Mycobacterium tuberculosis (MTB) infected Macrophages. Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Increased cell expression of CCR5 during M. tuberculosis infection Source: ISSN=ISSN 1810-6838, ISBN=, page=177 Year: 2005
Pulmonary Mycobacterium avium complex infection: association with NRAMP1 polymorphisms Source: Eur Respir J 2007; 30: 90-96 Year: 2007
In vitro and vivo study of isoxyl, a mycolic acid inhibitor for intermittent chemotherapy of multi drug resistant (MDR) strains of mycobacterium tuberculosis (M.tb)Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006
Airway epithelial expression of indoleamine 2,3-dioxygenase and resolution of local inflammatory cells Source: Annual Congress 2007 - The best of airway epithelial cells Year: 2007
Assessment of differential activity of reactive radicals in cell lines infected with Mycobacterium tuberculosis . Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018
The study of differential gene expression of matrix metalloproteinases in macrophages infected with Mycobacterium tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018
Re-activation of bovine tuberculosis in a patient treated with infliximab Source: Eur Respir J 2008; 32: 229-231 Year: 2008
IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis -infected human macrophages Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018 Year: 2019
Mycobacterium tuberculosis blocks phagolysosome maturation in alveolar macrophages of tuberculosis patients Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018